14.49

1.19% 0.2265

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$14.26

Aprire:

$14.24

Volume 24 ore:

546.35K

Relative Volume:

0.31

Capitalizzazione di mercato:

$2.17B

Reddito:

$113.31M

Utile/perdita netta:

$-57.51M

Rapporto P/E:

-10.65

EPS:

-1.36

Flusso di cassa netto:

$-20.55M

1 W Prestazione:

-3.80%

1M Prestazione:

-4.50%

6M Prestazione:

+128.32%

1 anno Prestazione:

+174.86%

Intervallo 1D:

$13.87

$14.53

Intervallo di 1 settimana:

$12.66

$15.27

Portata 52W:

$3.50

$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

268

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

WVE's Discussions on Twitter

Confronta WVE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE	14.47	2.17B	113.31M	-57.51M	-20.55M	-1.36
VRTX	446.39	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	740.49	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.15	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.56	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.47	24.49B	3.30B	-501.07M	1.03B	11.54

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

Nov 20, 2024

Insider Sale: President and CEO Paul Bolno Sells 51,234 Shares o - GuruFocus.com

Nov 17, 2024

Nov 16, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in Stock - MarketBeat

Nov 16, 2024

Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 By Investing.com - Investing.com UK

Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 - Investing.com India

Nov 15, 2024

WVEWave Life Sciences Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 15, 2024

What is HC Wainwright's Forecast for WVE FY2028 Earnings? - MarketBeat

Nov 15, 2024

Wave Life Sciences to Present at Jefferies London Healthcare Conference - The Manila Times

Nov 15, 2024

What is B. Riley's Estimate for WVE Q1 Earnings? - MarketBeat

Nov 15, 2024

US$22.20That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results - Simply Wall St

Nov 15, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 - Yahoo Finance

Nov 15, 2024

Leerink Partnrs Has Bullish Forecast for WVE FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 14, 2024

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 14, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - MarketBeat

Nov 14, 2024

Nov 13, 2024

WaVe Life Sciences's SWOT analysis: RNA editing stock faces pivotal year - Investing.com

Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 By Investing.com - Investing.com Nigeria

Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 - Investing.com India

Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook By Investing.com - Investing.com Australia

Nov 13, 2024

Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart

Nov 13, 2024

Wave Life Sciences (NASDAQ:WVE) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 13, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook - Investing.com

Nov 13, 2024